Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | GCGR | P47871 | 12/20 | 0.39 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.36 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.36 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.36 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1999286 | 0.86 | ADORA1 (0.49) | ADORA1PTGS1PTGS2ADORA2AHTR2A | |
| SCHEMBL15679983 | 0.81 | CNR1 (0.46) | ADORA1PTGS1PTGS2ADORA2AHTR2A | |
| SCHEMBL30009700 | 0.75 | MAPK14 (0.43) | PTGS1PTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL12277718 | 0.75 | MAPK14 (0.43) | PTGS1PTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL8008310 | 0.71 | MAPK14 (0.57) | ADORA2AMAPK14MAPK10 | |
| SCHEMBL27903531 | 0.70 | MAPK1 (0.42) | PTGS1PTGS2MAPK14 | |
| SCHEMBL12796013 | 0.69 | NOS3 (0.31) | — | |
| SCHEMBL22184930 | 0.69 | GPR55 (0.40) | PTGS1PTGS2 | |
| SCHEMBL28320987 | 0.69 | GCGR (0.51) | GCGR | |
| SCHEMBL24046599 | 0.68 | CKS1B (0.53) | ADORA1ADORA2AKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008149828-A1 | ORGANOMETALLIC COMPLEX, AND LIGHT-EMITTING MATERIA LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008149828-A1 | ORGANOMETALLIC COMPLEX, AND LIGHT-EMITTING MATERIA LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-12-11 | — | — | WO | disclosed |
| US-20080305361-A1 | Organometallic Complex, and Light-Emitting Material, Light-Emitting Element, Light-Emitting Device and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-12-11 | — | — | US | disclosed |
| US-20080305361-A1 | Organometallic Complex, and Light-Emitting Material, Light-Emitting Element, Light-Emitting Device and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-12-11 | — | — | US | disclosed |
| US-20080305361-A1 | Organometallic Complex, and Light-Emitting Material, Light-Emitting Element, Light-Emitting Device and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305361-A1 | Organometallic Complex, and Light-Emitting Material, Light-Emitting Element, Light-Emitting Device and Electronic Device | CRY1, CCNE2, IK | ADORA1 2881/4885PTGS1 2306/4885PTGS2 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.